ARCHIVES

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

This article is from The Cancer Letter archive.

Vol. 22 No. 03 | January 19, 1996

Download PDF Visit The Full Archive

Related Articles

Lung cancer screening trial reaches accrual goal of 50,000.

January 30, 2004

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

June 7, 2002

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006